KneeVoice

KneeVoice

Early Stage

Noninvasive diagnostic and monitoring platform for cartilage degradation in the knee

Noninvasive diagnostic and monitoring platform for cartilage degradation in the knee

Overview

Raised to Date: Raised: $161,928

Total Commitments ($USD)

Platform

Microventures

Start Date

03/29/2022

Close Date

08/29/2022

Min. Goal
$24,995
Max. Goal
$1,069,998
Min. Investment

$111

Security Type

Equity - Preferred

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$27.68

Pre-Money Valuation

$10,000,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

09/03/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,058

# of Investors

128

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

High

Location

Santa Monica, California

Business Type

Growth

KneeVoice, with a valuation of $10 million, is raising funds on MicroVentures. The company is developing a non-invasive device that monitors cartilage degradation in the knees. The platform is being built with neural network, artificial intelligence, and machine learning capabilities and will capture sounds, vibrations, and positions emitted by the knee to monitor the health of knee joints. KneeVoice has filed FDA pre-submission in January 2022 and completed clinical trials in several health centers in the US. Gustavo De Greiff, Felipe Rigby, and Dr. Carlos Leal founded KneeVoice in June 2016. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1,070,000. The campaign proceeds will be used for wearable product development, software, wearable product inventory, diagnostic product inventory, and marketing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-25,171

$-40,269

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$5,064

$16,173

Accounts Receivable

$0

$0

Total Assets

$438,575

$429,684

Short-Term Debt

$213,723

$179,661

Long-Term Debt

$116,000

$116,000

Total Liabilities

$329,723

$295,661

Financials as of: 03/29/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
KneeVoice on MicroVentures 2022
Platform: Microventures
Security Type: Equity - Preferred
Valuation: $10,000,000
Price per Share: $27.68

Follow company

Follow KneeVoice on MicroVentures 2022

Buy KneeVoice's Deal Report

Warning: according to the close date for this deal, KneeVoice may no longer be accepting investments.

KneeVoice Deal Report

Get KingsCrowd’s comprehensive report on KneeVoice including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether KneeVoice is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the KneeVoice deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge